Brand Comparison
Creamy vs Rejuran
A head-to-head comparison of two popular K-beauty brands. Which one is right for your skin?
Our Pick
Rejuran
Higher editor rating (8.7 vs 8.5)
Creamy
Creamy is what happens when a Brazilian dermatologist (Dr. Luiz Romancini) decides the gap between prescription-grade actives and what patients can afford to use daily is too wide. Founded in 2019 in São Paulo, the brand hit R$1 billion in cumulative revenue faster than any Brazilian skincare brand in history. The Glicointense Peel (14% glycolic acid + BHA + PHA + LHA) is the hero — a multi-acid at-home peel that rivals professional treatments. The entire line follows the same principle: maximum active concentration that's still safe for home use, transparent percentages on the packaging, and pricing that makes daily compliance realistic. Available at every Drogasil, Droga Raia, and Beleza na Web in Brazil.
Pros
- ✓ founded by a practicing dermatologist — formulations are clinically informed
- ✓ transparent active percentages on every product
- ✓ R$1 billion in cumulative revenue — fastest-growing Brazilian skincare brand
- ✓ available at all major Brazilian pharmacy chains
Cons
- ✗ relatively small product range — focused lineup
- ✗ limited international availability
- ✗ packaging is clinical-functional, not aspirational
- ✗ newer brand — long-term track record still building
Rejuran
Rejuran is the consumer-skincare arm of Pharma Research Products, the Korean biopharma company that developed the original Rejuran Healer injectable — the same PDRN (polydeoxyribonucleotide) dermal treatment that's been a staple of Korean aesthetic clinics since 2014. The topical line translates that clinical DNA into daily-use products, anchored by the patented c-PDRN® complex at 0.5% concentration plus proprietary DOT® (Dermal Optimizing Technology) delivery. The Turnover Ampoule is the hero: a lightweight serum that targets fine lines, firmness, and texture with the same salmon-DNA active that made the injectable famous. Rejuran launched at Sephora US in 2024, won the 2025 Olive Young Slow Aging award, and has become the face of the PDRN trend that's dominating K-beauty in 2025–2026. The price point is premium-mid ($45–55), justified by the clinical pedigree and patented delivery system. Worth reaching for if you want the PDRN trend from the company that actually invented it.
